Cargando…
Application of siRNA Against SARS in the Rhesus Macaque Model
Containment of the SARS coronavirus (SCV) outbreak was accompanied by the rapid characterization of this new pathogen's genome sequence in 2003, encouraging the development of anti-SCV therapeutics using short interfering RNA (siRNA) inhibitors. A pair of siRNA duplexes identified as potent SCV...
Autores principales: | Tang, Qingquan, Li, Baojian, Woodle, Martin, Lu, Patrick Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121115/ https://www.ncbi.nlm.nih.gov/pubmed/18369784 http://dx.doi.org/10.1007/978-1-59745-191-8_11 |
Ejemplares similares
-
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque
por: Li, Bao-jian, et al.
Publicado: (2005) -
Modulation of angiogenesis with siRNA inhibitors for novel therapeutics
por: Lu, Patrick Y., et al.
Publicado: (2005) -
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
por: Xie, Frank Y., et al.
Publicado: (2006) -
Targeted Delivery of siRNA Therapeutics to Malignant Tumors
por: Leng, Qixin, et al.
Publicado: (2017) -
Polyethyleneimine (PEI) Mediated siRNA Gene Silencing in the Schistosoma mansoni Snail Host, Biomphalaria glabrata
por: Knight, Matty, et al.
Publicado: (2011)